V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014568 | 220014883 | 1.59 | 97.5 | Palliative (P) | 2017-10-30 | 2017-10-30 | PACLITAXEL | N | N | 220034505 | PACLITAXEL |
| 220014569 | 220009169 | null | 90 | Palliative (P) | 2014-10-31 | 2014-10-31 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220034510 | ALEMTUZUMAB |
| 220014570 | 220009169 | 1.79 | 64 | Palliative (P) | 2016-09-23 | 2016-09-23 | CARBOPLATIN + PACLITAXEL | 02 | N | 220034510 | CARBOPLATIN + PACLITAXEL |
| 220014571 | 220009169 | 1.6 | 69 | null | null | 2016-05-21 | Methotrexate + Folinic acid | N | N | 220034510 | ECX |
| 220014572 | 220009169 | 1.6 | 55 | Palliative (P) | 2014-12-05 | 2014-12-28 | GEMTUZUMAB OZOGAMICIN | N | N | 220034510 | UKALL2014 |
| 220014573 | 220022218 | 1.84 | 80 | Palliative (P) | 2013-08-10 | 2013-08-22 | Clofarabine + Cytarabine | N | N | 220034521 | CLOFARABINE + CYTARABINE |
| 220014574 | 220009170 | 1.6 | 74.4 | Palliative (P) | 2017-07-23 | 2017-07-30 | Clofarabine + Cytarabine | N | N | 220034522 | CLOFARABINE + CYTARABINE |
| 220014575 | 220009171 | 1.71 | 66.2 | Curative (C) | 2013-10-25 | 2013-10-25 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220034524 | PACLITAXEL |
| 220014576 | 220009173 | 1.6 | 79.9 | Palliative (P) | 2017-04-17 | 2017-05-01 | UKALL14- Ph 1 Induction | N | N | 220034531 | PONATINIB |
| 220014577 | 220009175 | 1.65 | 57.8 | Palliative (P) | null | 2017-02-27 | Alemtuzumab cond (RI ALLO CAMP100) | N | null | 220034535 | ALEMTUZUMAB |
| 220014578 | 220009176 | 1.96 | 0 | Palliative (P) | 2016-02-15 | 2016-02-22 | Paclitaxel 7 day | N | N | 220034543 | PACLITAXEL |
| 220014579 | 220014887 | 1.69 | 77.1 | Palliative (P) | 2015-08-22 | 2015-09-21 | Cytarabine intrathecal | N | null | 220034543 | CYTARABINE INTRATHECAL |
| 220014580 | 220014888 | 1.71 | 92.3 | Curative (C) | null | 2017-11-30 | UKALL14- Intens/CNS Proph | N | N | 220034556 | GEMCARBO |
| 220014581 | 220009179 | null | 85.2 | Curative (C) | 2013-09-10 | 2013-10-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220034562 | METHOTREXATE |
| 220014582 | 220009181 | 1.6 | 68.7 | Curative (C) | 2014-12-29 | 2015-04-27 | Irinotecan + Modified De Gramont | 02 | N | 220034567 | FBC |
| 220014583 | 220009183 | 1.69 | 73.25 | Palliative (P) | 2015-12-30 | 2016-01-06 | IDARUBICIN | N | N | 220034571 | IDARUBICIN |
| 220014584 | 220018129 | 1.8 | 79 | Palliative (P) | null | 2016-05-31 | ECX | null | N | 220034573 | DOCETAXEL |
| 220014585 | 220009186 | null | 75 | Curative (C) | 2017-01-14 | 2017-02-28 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220034576 | CARBOPLATIN + PACLITAXEL |
| 220014586 | 220014893 | 1.65 | 64.35 | Palliative (P) | 2018-08-28 | 2018-08-28 | CARBOPLATIN + PACLITAXEL | N | N | 220034579 | CARBOPLATIN + PACLITAXEL |
| 220014588 | 220014894 | 0 | 98 | Disease modification (D) | null | 2015-12-09 | Cytarabine intrathecal | N | null | 220034588 | CYTARABINE INTRATHECAL |
| 220014589 | 220009189 | 1.5 | 58.2 | null | 2014-10-09 | 2014-10-14 | Irinotecan + Modified De Gramont | 2 | N | 220034596 | ECX |
| 220014590 | 220009191 | 1.84 | 77.5 | Curative (C) | 2015-05-23 | 2015-05-26 | PONATINIB | 2 | N | 220034605 | DOCETAXEL |
| 220014591 | 220014895 | 1.74 | null | Palliative (P) | 2016-01-11 | 2016-01-16 | Cytarabine intrathecal | N | N | 220034611 | CYTARABINE INTRATHECAL |
| 220014592 | 220009195 | 1.66 | 71 | Palliative (P) | 2017-08-31 | 2017-09-01 | Clofarabine + Cytarabine | N | N | 220034611 | OXALIPLATIN + MDG |
| 220014593 | 220009195 | 1.67 | 100.5 | Palliative (P) | 2018-02-10 | 2018-02-10 | UKALL 14 TRIAL | N | N | 220034611 | GEMCARBO |
| 220014595 | 220009196 | 1.57 | 107 | Curative (C) | 2013-02-06 | 2014-10-20 | Oxaliplatin + Modified de Gramont | N | N | 220034623 | PONATINIB |
| 220014596 | 220009198 | 1.66 | 65.9 | Palliative (P) | 2015-03-15 | 2015-03-15 | Carboplatin + Etoposide iv&po | 2 | N | 220034626 | CARBOPLATIN + ETOPOSIDE |
| 220014597 | 220009199 | 1.63 | 58 | Palliative (P) | 2016-08-28 | 2016-09-29 | Cytarabine intrathecal | 99 | N | 220034633 | CYTARABINE INTRATHECAL |
| 220014598 | 220009200 | 1.7 | 77 | Disease modification (D) | 2016-05-26 | 2016-06-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220034635 | CARBOPLATIN + PACLITAXEL |
| 220014599 | 220009202 | 1.74 | 80 | null | 2015-04-22 | 2015-04-23 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220034644 | CARBOPLATIN + PACLITAXEL |
| 220014600 | 220009203 | 1.7 | 109.8 | null | 2015-11-05 | 2015-11-30 | Alemtuzumab(INTRAVENOUS) | 02 | N | 220034651 | ALEMTUZUMAB |
| 220014601 | 220009204 | 1.63 | 58.8 | Palliative (P) | null | 2016-08-28 | Clofarabine + Cytarabine | N | N | 220034652 | OXALIPLATIN + MDG |
| 220014602 | 220014897 | null | 64 | Palliative (P) | 2017-12-20 | 2017-12-25 | Docetaxel | N | null | 220034654 | IRINOTECAN + MDG |
| 220014603 | 220009205 | null | null | Palliative (P) | 2016-03-10 | 2016-03-22 | UKALL14- Ph 2 Induction | N | N | 220034661 | CLOFARABINE + CYTARABINE |
| 220014604 | 220014898 | 1.71 | 46.6 | Palliative (P) | null | 2016-01-11 | Paclitaxel 7 day | 1 | N | 220034662 | PACLITAXEL |
| 220014605 | 220014898 | 1.9 | 61.85 | Palliative (P) | 2017-09-15 | 2017-11-08 | IDARUBICIN | N | null | 220034662 | IDARUBICIN |
| 220014606 | 220009206 | 1.83 | 87.1 | Palliative (P) | 2013-09-02 | 2013-09-02 | IDARUBICIN | N | null | 220034670 | IDARUBICIN |
| 220014609 | 220009211 | 1.69 | 57 | Disease modification (D) | 2016-02-28 | 2016-03-01 | UKALL14- Intens/CNS Proph | 2 | N | 220034675 | FBC |
| 220014610 | 220009212 | 1.77 | 69 | Palliative (P) | 2017-09-22 | 2017-10-03 | UKALL14- Ph 1 Induction | N | N | 220034678 | PONATINIB |
| 220014611 | 220009215 | 1.57 | 64 | Disease modification (D) | null | 2017-05-12 | Carboplatin + Etoposide IV 3 day | null | null | 220034678 | CARBOPLATIN + ETOPOSIDE |
| 220014612 | 220009217 | 1.78 | 88 | Palliative (P) | 2016-03-30 | 2016-03-30 | FLUOROURACIL + OXALIPLATIN | 2 | N | 220034690 | PONATINIB |
| 220014613 | 220009221 | 1.73 | null | Palliative (P) | 2017-11-13 | 2017-11-17 | FLUOROURACIL + IRINOTECAN | 02 | N | 220034691 | OXALIPLATIN + MDG |
| 220014614 | 220009222 | 1.76 | null | Palliative (P) | 2015-01-26 | 2015-04-14 | UKALL14- Ph 2 Induction | N | N | 220034692 | PONATINIB |
| 220014615 | 220014906 | 1.72 | 43 | Palliative (P) | 2013-06-27 | 2013-06-27 | Clofarabine + Cytarabine | 2 | N | 220034697 | FLUDARABINE + MELPHALAN |
| 220014616 | 220014907 | 1.74 | 46.7 | Disease modification (D) | 2017-02-25 | 2017-02-25 | GEMCARBO | 01 | null | 220034700 | METHOTREXATE |
| 220014617 | 220014907 | 1.56 | 43 | Curative (C) | 2014-10-02 | 2014-10-06 | Irinotecan + Modified De Gramont | N | N | 220034700 | FBC |
| 220014618 | 220009225 | 1.56 | 40.9 | Curative (C) | 2015-06-18 | 2015-06-19 | ECX | 02 | N | 220034712 | CLOFARABINE + CYTARABINE |
| 220014619 | 220009225 | 1.77 | 71.2 | Palliative (P) | 2014-08-08 | 2014-08-20 | PONATINIB | N | N | 220034712 | DOCETAXEL |
| 220014620 | 220009227 | 1.73 | 90.9 | Palliative (P) | 2013-02-01 | 2013-07-02 | CARBOPLATIN + PACLITAXEL | 02 | N | 220034715 | CARBOPLATIN + PACLITAXEL |
| 220014621 | 220009227 | null | 78.8 | Adjuvant (A) | 2015-01-06 | 2015-01-10 | Carboplatin + Etoposide iv&po | null | null | 220034715 | CARBOPLATIN + ETOPOSIDE |